Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538860 · ClinicalTrials.gov registry record · NA
Validation of an Automated Online Language Interpreting Tool - Phase Two.
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT03538860: Completed NA study, sponsored by University of California, Davis.
NCT03538860 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538860, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to high quality, mental health services for diverse populations by improving the flow of clinical work across care settings (primary care and specialty care) through the use of innovative online asynchronous methods of language interpretation and clinical communication. The investigators are conducting a two phase study. The first phase is completed and involved developing and testing the interpreting tool. The second phase of the research is a clinical trial to compare two methods of cross-language psychiatric assessment.
Primary Outcome
Diagnosis accuracy with respect to gold standard SCID for Method B will be evaluated against Method A.
Interventions
- BEHAVIORAL Active comparator: Human interpreter
- BEHAVIORAL Intervention: Asynchronous Telepsychiatry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT03538860 record still lists
NCT03538860 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Active comparator: Human interpreter is the first listed.
NCT03538860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03538860 about?
NCT03538860 is a clinical study titled "Validation of an Automated Online Language Interpreting Tool - Phase Two.". There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to...
What is the current status of trial NCT03538860?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2017-11-14. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03538860?
The interventions under investigation include: Active comparator: Human interpreter (BEHAVIORAL), Intervention: Asynchronous Telepsychiatry (BEHAVIORAL).
Who is sponsoring clinical trial NCT03538860?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03538860's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI